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Biochemical reactions, even those as com-
plex as replicating the DNA genome of cells,
follow the principle that the process is regu-
lated by both the substrate concentration
and by the enzymes that mediate the pro-
cess. Deoxynucleoside triphosphates (dNTPs),
the substrates for DNA polymerizing en-
zymes, have long been known to be limited
in their concentration in cells because the
enzyme that synthesizes deoxynucleotides
from ribonucleotides, ribonucleotide re-
ductase (RNR), is synthesized and enzy-
matically activated as cells enter the S phase
(1, 2). RNR, discovered by Peter Reichard
52 y ago (3), converts all four ribonucleo-
tide diphosphates (rNDPs) to the respective
deoxynucleoside disposphates (dNDPs),
which are then rapidly converted to dNTP.
Low levels and activity of RNR provide suf-
ﬁcient dNTPs for mitochondrial DNA syn-
thesis and for DNA repair in noncycling
cells and during the G1 phase of the cell-
division cycle in proliferating cells, but RNR
levels and activity are hugely increased as
cells commit to replicate DNA during the S
phase of the cell-division cycle or following
extensive DNA repair (4). Indeed, RNR is
one of the most highly regulated enzymes
known. The mammalian enzyme synthe-
sizes all four dNDPs in a cycle, is allosteri-
cally activated by dATP, dTTP, and dGTP
to balance the relative levels of the four
dNTPs (dCTP, dTTP, dGTP and dATP),
and is feed-back–inhibited by dATP, be-
cause dATP is the last dNTP to be made
in the cycle of synthesizing all four dNTPs
by a single RNR enzyme (1). Speciﬁc in-
hibitory proteins (in yeasts) also control
RNR activity and RNR subunit levels are
regulated by cell cycle-dependent transcrip-
tion of the genes encoding the subunits and
by subunit protein stability (4, 5). On the
basis of these observations, one might ex-
pect that dNTP synthesis by RNR should
be sufﬁcient to control how and when ge-
nome DNA replication occurs because RNR
is only maximally active during the S phase.
However, recent studies, including those
emerging from far-aﬁeld studies of how
HIV replication is restricted to certain cell
types (6, 7), have uncovered a new control
of dNTP levels, dNTP destruction. The
sterile alpha motif and HD-domain con-
taining protein 1 (SAMHD1) protein is a
deoxynucleoside triphosphohydrolase that
cleaves dNTPs to the respective deoxynu-
cleoside and a triphosphate (8). In PNAS,
Franzolin et al. (9) show that dNTP de-
struction by SAMHD1 also contributes to
dNTP concentration control during the cell-
division cycle of proliferating cells, thereby
affecting both DNA replication and cell-
cycle progression.
SAMHD1 contains two recognized do-
mains, a SAM (sterile alpha motif) domain
of unknown function, and a HD domain
that contains catalytic aspartic acid and
histidine residues that form the catalytic
core of the enzyme (8). SAMHD can only
hydrolyze dGTP when each dNTP is pro-
vided individually, but it can hydrolyze
dTTP, dCTP, and dATP when dGTP is
present as a cofactor. dGTP most likely acts
as an allosteric activator of the dimeric en-
zyme (8), although a recent report suggests
that the enzyme may function as a tetramer
(10). The observation that SAMHD1 can
degrade dGTP alone and that the same
dNTP can allosterically activate the tri-
phosphohydrolase may be one mechanism
to balance the concentrations of all four
dNTPs in the cell. It is possible that the
levels of dNTP are determined by the afﬁnity
of dGTP to the allosteric site of SAMHD1.
Franzolin et al. (9) demonstrate that
SAMHD1 is intimately involved in the control
of dNTP levels, not only in noncycling cells
where the enzyme is abundantly expressed,
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Fig. 1. A generic eukaryotic cell division cycle showing cyclin A-CDK2 activity and the relative levels of dNTPs. The
dNTP-synthesizing enzyme activity of RNR and the relative activity of the dNTP triphosphohydrolase activity of
SAMHD1 alternate out of phase with each other. Possibly, cyclin A-CDK2 phosphorylates SAMHD1 and promotes its
destruction via ubiquitin-mediated proteolysis, allowing dNTP synthesis by RNR to be coupled to DNA replication
during the S phase. This cycle parallels the cycle of assembly of prereplicative complexes (pre-RC) in the G1 phase and
its destruction as cells enter into the S phase, a process driven by cyclin A-CDK2.
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up-ends the previous notion that the syn-
thesis of dNTPs by RNR was the main
mechanism that regulated the intracellular
concentration of dNTPs during the cell cy-
cle. SAMHD1 is present in the nucleus of
G1-phase cells, whereas RNR subunits are
prominent in the cytoplasm, increasing
their levels in S-phase cells (9). Depletion
of SAMHD1 levels in cycling cells in-
creased the dNTP concentration in non–
S-phase cells and caused an arrest in the
G1 phase. Interestingly, deregulation of
the feedback inhibition of RNR in yeast
cells caused elevated dNTP levels and an
arrest in the G1 phase, so dNTPs levels
have a direct effect on control of cell-cycle
progression (11). Uncontrolled and high
dNTP concentrations are known to be mu-
tagenic for genome replication (12), which
is most likely why cells go to great lengths
to couple intimately the concentration of all
four dNTPs to DNA synthesis during the
S phase.
The gene encoding SAMHD1 was discov-
ered as an IFN-γ–induced gene in mouse
peritoneal macrophages (13). Induction of
SAMHD1 in differentiated cells now makes
sense because only low levels of dNTP would
be required in nonproliferating cells to main-
tain mitochondria and for DNA repair. It is
probable that high dNTP levels may cause
problems with maintenance of mitochondrial
function, which might occur in patients with
Aicardi–Goutières Syndrome (AGS), a genet-
ically inherited inﬂammatory encephalopathy
that clinically resembles congenital virus in-
fections and certain types of autoimmunity
(14). AGS mutations in the SAMHD1 gene
reduce either catalytic activity or the allosteric
activation by dGTP, both causing an increase
in intracellular dNTP levels, which may con-
tribute to defective differentiation of innate
immune cells.
Of interest is the observation that
SAMHD1 restricts certain lentiviruses, in-
cluding HIV1, from replicating in non-
cycling cells because the levels of dNTP are
not sufﬁcient for the reverse transcriptase
to copy the incoming RNA template. Some
lentiviruses, such as HIV2 and the Simian
Immunodeﬁciency Virus, carry in a protein
called Vpx that causes the degradation of
SAMHD1, thereby allowing an increase in
dNTPs and copying of the RNA genome
into DNA (6, 8, 15). The Km for different
reverse transcriptases vary and contribute
to the host cell-speciﬁcity for virus replica-
tion, a process inﬂuenced by the presence
or absence of SAMHD1 (16). The pheno-
type of AGS is consistent with SAMHD1
mutations causing higher dNTP levels that,
in turn, could lead to more robust virus
infection for viruses that have a DNA poly-
merase with a Km that requires increased
dNTP levels. However, only viruses that
encode their own DNA polymerizing
enzymes will replicate in noncycling cells,
because the cellular machinery that repli-
cates host DNA is not active. Once the po-
tent dNTP triphophohydrolase activity of
SAMHD1 is removed, the virus polymerase
can replicate the virus genome. Thus, DNA
viruses, such as herpes simplex virus type 1
and vaccinia virus, which encode their own
DNA polymerases, can replicate in noncy-
cling cells if SAMHD1 is removed (17).
The striking observation by Franzolin et al.
(9), that in cycling cells SAMHD1 is not pres-
ent in the S phase, suggests that it is degraded
by ubiquitin-dependent proteolysis as cells
transit from the G1 phase into the S phase.
The SAMHD1 protein can be phosphory-
lated by cyclin A-CDK2 (18). This kinase is
activated at the G1-to-S phase transition in
human cells and is responsible for initiation
of actual DNA synthesis from prereplicative
complexes that have been assembled during
the G1 phase at all origins of DNA replica-
tion (19). One possibility is that phosphory-
lation of SAMHD1 primes Ub-mediated
proteolysis of the enzyme at the G1-to-S
phase transition (Fig. 1).
Recent studies have shown that SAMHD1
is phosphorylated at a CDK site, T592
(18, 20). Mutations that alter or mimic phos-
phorylation at this residue lost their ability
to restrict HIV replication. These mutants
retained their ability to hydrolyze TTP in
the presence of dGTP and did not alter
dNTP levels in cells (20). Based on these
observations, the possibility was raised that
the ability of SAMHD1 to restrict retrovirus
replication was not because of its ability to
degrade cellular dNTPs. However, this con-
clusion must now be tempered in light of the
recent results from Franzolin et al. (9), be-
cause the dNTP levels in cells expressing
wild-type versus mutant SAMHD1 were mea-
sured in noncycling cells (PMA-stimulated
U937 myeloid cells). In contrast, the ability
of the wild-type and mutant proteins to
restrict retroviral replication was measured
in cycling cells. Perhaps in the noncycling
cells the dNTP phosphohydrolase activity
is not affected by phosphorylation be-
cause the kinase is absent, or the relevant
E3-ligase that mediated Ub-dependent deg-
radation of SAMHD1 is not expressed. In
cycling cells, however, both cyclin A-CDK2
and the E3-ligase could induce destruction
of SAMHD1, increasing dNTP levels and
allowing virus replication. Clearly, future
studies are needed to explore how SAMHD1
levels are controlled in both cycling and
noncycling cells. Importantly, the observa-
tion that only G1-phase cycling cells ex-
press SAMHD1 will have to be taken into
consideration in interpreting results on
how SAMHD1 activity affects both genome
and virus DNA replication and how dNTPs
may affect cellular function in innate im-
munity. Despite 52 y of investigating dNTP
metabolism, there appears to be much
more to do!
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